[1]李金锋.妊娠期高血压疾病患者血浆组织型纤溶酶原激活物及其抑制物的活性变化[J].新乡医学院学报,2009,26(01):069-70.
点击复制

妊娠期高血压疾病患者血浆组织型纤溶酶原激活物及其抑制物的活性变化/HTML
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
26
期数:
2009年01期
页码:
069-70
栏目:
临床研究
出版日期:
2009-01-20

文章信息/Info

Title:
Activity of plasma tissue plasminogen activator and plasminogen activator inhibitor in patients with hypertensive disorder complicating pregnancy
作者:
李金锋
驻马店市中心医院妇产科
关键词:
妊娠期高血压疾病 纤溶酶原激活物 纤溶酶原激活物抑制物
Keywords:
hypertensive disorder complicating pregnancy tissue plasminogen activator plasminogen activator inhibitor

相似文献/References:

[1]申 霞.妊娠期高血压病患者血清细胞粘附分子-1 和白细胞介素-6 的变化[J].新乡医学院学报,2006,23(05):522.
[2]马涵英,赵铁夫,温绍君,等.组织型纤溶酶原激活物及其抑制物与静脉血栓栓塞症的关系[J].新乡医学院学报,2011,28(06):000.
[3]马涵英,赵铁夫,温绍君,等.组织型纤溶酶原激活物及其抑制物与静脉血栓栓塞症的关系[J].新乡医学院学报,2011,28(06):000.
[4]王晋萍,李占辉.丹参注射液和硫酸镁联合治疗对妊娠期高血压疾病患者分娩结局及血清脂联素表达的影响[J].新乡医学院学报,2016,33(9):764.[doi:10.7683/xxyxyxb.2016.09.006]
 WANG Jin-ping,LI Zhan-hui.Effect of Danshen injection combined with magnesium sulfate on the outcome of childbirth and serum adiponectin in patients with hypertensive disorders of pregnancy[J].Journal of Xinxiang Medical University,2016,33(01):764.[doi:10.7683/xxyxyxb.2016.09.006]
[5]袁雪莲,曲首辉.妊娠期高血压疾病患者血清β-痕迹蛋白和尿β2-微球蛋白水平与早期肾损伤的相关性[J].新乡医学院学报,2019,36(3):238.[doi:10.7683/xxyxyxb.2019.03.008]
 YUAN Xue-lian,QU Shou-hui.Correlation between the levels of serum β-trace protein and urinary β2-microglobulin and early renal injury in patients with gestational hypertension[J].Journal of Xinxiang Medical University,2019,36(01):238.[doi:10.7683/xxyxyxb.2019.03.008]
[6]张莉莉,关丫丫,张林波.血清同型半胱氨酸、中性粒细胞明胶酶相关脂质运载蛋白联合尿微量白蛋白对妊娠期高血压疾病患者早期肾损伤的诊断价值[J].新乡医学院学报,2022,39(2):177.[doi:10.7683/xxyxyxb.2022.02.016]
 ZHANG Lili,GUAN Yaya,ZHANG Linbo.Diagnostic value of serum homocysteine,neutrophil gelatinase-associated lipid carrier protein and urinary microalbumin for early renal injury of patients with hypertensive disease of pregnancy[J].Journal of Xinxiang Medical University,2022,39(01):177.[doi:10.7683/xxyxyxb.2022.02.016]

更新日期/Last Update: 2013-12-30